Your session is about to expire
← Back to Search
Pharmacist-Assisted Medication Transition for Care Transitions
Study Summary
This trial evaluates whether having a pharmacist help with a patient's transition from hospital to SNF decreases the number of medication-related problems.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 4 trial • 494 Patients • NCT03688100Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am younger than 18 years old.I am being discharged to enter hospice care.
- Group 1: Clinical Pharmacist in Transition of Care
- Group 2: Patient transitions from hospital to post-acute care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots left for participation in this research?
"Affirmative. Data on clinicaltrials.gov reveals that this scientific investigation, which was publicized on the 31st of January 2022, is actively seeking patients. 5760 individuals have to be enrolled from a single medical facility."
How many individuals are involved in this experimental program?
"Affirmative. According to information on clinicaltrials.gov, this medical experiment is still accepting patients at the present moment. It was initially publicised on January 31st 2022 and modified most recently on February 11th 2022; 5760 participants are needed from 1 research site."
Share this study with friends
Copy Link
Messenger